Postoperative Apixaban Management
For low bleeding risk surgery, resume apixaban 5 mg twice daily 24 hours after surgery; for high bleeding risk surgery, resume 48-72 hours postoperatively, and continue indefinitely based on your underlying indication (atrial fibrillation, VTE treatment, or VTE prophylaxis). 1
Timing of Resumption Based on Surgical Bleeding Risk
The critical decision point is determining your surgery's bleeding risk category:
Low Bleeding Risk Surgery
- Resume apixaban 5 mg twice daily starting 24 hours after surgery 1
- Examples: minor dental procedures, skin procedures, cataract surgery, laparoscopic procedures with minimal tissue trauma
High Bleeding Risk Surgery
- Resume apixaban 48-72 hours (2-3 days) after surgery 1
- For patients at high thromboembolism risk, consider starting with reduced dose apixaban 2.5 mg twice daily for the first 2-3 days, then increase to full dose 5 mg twice daily 1
- Examples: major abdominal surgery, neurosurgery, spinal procedures, major orthopedic surgery
Duration of Therapy
The duration depends entirely on your indication for anticoagulation, NOT your comorbidities:
- Atrial fibrillation: Continue indefinitely (lifelong therapy) 2
- VTE treatment: Typically 3-6 months minimum, potentially longer based on VTE risk factors 2
- Post-orthopedic surgery prophylaxis: 10-14 days for knee replacement, 32-38 days for hip replacement 2, 3
Your diabetes, hypertension, and hypercholesterolemia do not independently determine apixaban duration—these are cardiovascular risk factors but the anticoagulation indication drives the timeline.
Important Considerations
Renal function monitoring is critical postoperatively 2. If your surgery or medical condition could affect kidney function, creatinine clearance should be checked and apixaban dosing adjusted accordingly. Standard dose is 5 mg twice daily, but reduce to 2.5 mg twice daily if you meet 2 of 3 criteria: age ≥80 years, weight ≤60 kg, or serum creatinine ≥1.5 mg/dL 2.
Adequate hemostasis must be confirmed before resuming therapeutic doses 1, 2. The rapid onset of action (peak levels at 3 hours) means you need to ensure surgical bleeding is controlled 1.
Bridging with heparin is NOT needed in most cases 2. The 2017 French guidelines and 2022 CHEST guidelines explicitly state no preoperative or postoperative heparin bridging is required except in very high thrombotic risk situations.
Common Pitfalls
The most recent high-quality evidence from the PAUSE trial (2022) 4 demonstrated that standardized DOAC interruption (1 day before/after for low-risk, 2 days before/after for high-risk procedures) resulted in very low rates of thromboembolism (0.16-0.60%) and major bleeding (0.9-1.85%). This validates the conservative approach of waiting 24-72 hours postoperatively rather than rushing to resume anticoagulation.
Do not confuse prophylactic dosing (2.5 mg twice daily for orthopedic surgery) with therapeutic dosing (5 mg twice daily for atrial fibrillation/VTE) 2, 3. Your maintenance dose after the perioperative period returns to your pre-surgical indication-based regimen.